Clinical trial
Safety and Efficacy of Suxiao Jiuxin Pill for Prevention of Acute Mountain Sickness: a Randomized Controlled Trial
NCT06531161 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Suxiao Jiuxin Pill for Prevention of Acute Mountain Sickness: a Randomized Controlled Trial
- Lead sponsor
- Peking University First Hospital
- Phase
- Phase 2/3
- Overall status
- Not yet recruiting
- Start date
- August 31, 2024
- Completion date
- September 30, 2025
- Enrollment
- 168 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acute mountain sickness